DBISX
Price
$12.01
Change
-$0.03 (-0.25%)
Updated
Jun 2 closing price
Net Assets
181.67M
MBXCX
Price
$43.66
Change
-$0.14 (-0.32%)
Updated
Jun 2 closing price
Net Assets
10.13B
Interact to see
Advertisement

DBISX vs MBXCX

Header iconDBISX vs MBXCX Comparison
Open Charts DBISX vs MBXCXBanner chart's image
DBISX vs MBXCX Comparison Chart in %
View a ticker or compare two or three
VS
DBISX vs. MBXCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBISX is a Buy and MBXCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXCX has more cash in the bank: 10.1B vs. DBISX (182M). DBISX pays higher dividends than MBXCX: DBISX (1.74) vs MBXCX (0.00). DBISX was incepted earlier than MBXCX: DBISX (25 years) vs MBXCX (10 years). MBXCX (3.00) is less costly to investors than DBISX (1.31). MBXCX is a more actively managed with annual turnover of: 19.00 vs. DBISX (12.00). DBISX has a lower initial minimum investment than MBXCX: DBISX (1000) vs MBXCX (2500). MBXCX annual gain was more profitable for investors over the last year : 20.16 vs. DBISX (12.93). MBXCX return over 5 years is better than : 30.60 vs. DBISX (23.44).
DBISXMBXCXDBISX / MBXCX
Total Expense Ratio1.123.0037%
Annual Report Gross Expense Ratio1.313.0044%
Fund Existence25 years10 years-
Gain YTD4.22012.97433%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets182M10.1B2%
Annual Yield % from dividends1.740.00-
Returns for 1 year12.9320.1664%
Returns for 3 years27.3533.9481%
Returns for 5 years23.4430.6077%
Returns for 10 years69.2986.0781%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRWCX37.91N/A
N/A
T. Rowe Price Capital Appreciation
MSFBX26.29N/A
N/A
Morgan Stanley Inst Global Franchise A
BRTNX79.58N/A
N/A
Bretton Fund
TRHBX30.31N/A
N/A
Nuveen Small Cap Blend Idx I
AIQQX21.19N/A
N/A
Aristotle Value Equity I-2